Mumbai, Maharashtra, India
Demographic changes, increase in the baby boomer population and enhanced importance to wound care are major factors driving growth in the wound debridement markets across Europe.
Frost & Sullivan (http://www.medicaldevices.frost.com) finds that the European markets for wound debridement earned revenues of $166.0 million in 2005 and estimates this to reach $289.0 million in 2012.
If you are interested in a virtual brochure, which provides manufacturers, end users, and other industry participants with an overview of the latest analysis of the European Markets for Wound Debridement (BA1A-54), send an e-mail to Shwetha Thomas, Corporate Communications, at sthomas@frost.com with your full name, company name, title, telephone number, fax number, e-mail address, city, state and country. Upon receipt of the above information, an overview will be sent to you by e-mail.
"The wound debridement markets are shifting from their traditional and product-driven focus to greater importance to cost-efficient, sophisticated instruments and treatments," notes Frost & Sullivan Research Analyst Ms. Sowmya Rajagopalan. "Henceforth, the benefits of cost efficiency, painless treatment, easy availability and user-friendly features will be the key driving factors fuelling the adoption of wound debridement products."
The efficiency of the products to treat wounds completely and the speed of debriding are crucial factors influencing market expansion. The products are focussed on painless treatment and the range includes sophisticated ultrasound and laser debridement instruments, as well as medical maggots, which are used to debride wounds biologically. New super oxidized solutions and enzymes are also being used for debridement.
Despite these positive trends, varying healthcare reforms and reimbursement regulations in different countries have led to increased pricing pressure and impediments in product manufacturing. Thus, market participants are faced with the challenge of meeting diverse specifications and standards across the European countries. In addition, large-scale purchasing trends of hospitals have compounded pricing issues. Other factors affecting the market are the lack of standardised treatments and spiralling competition due to the existence of too many products.
"The growing trend towards price reduction and the implementation of regulatory policies that restrict the use of certain products are hampering market progress," states Ms. Rajagopalan. "Market participants would do well to align themselves with others in order to gain from the mutual benefits of such a strategy. Yet another alternative would be to develop the ability to manufacture a completely unique product that can fulfil the standards set by different health care organisations in Europe."
In view of the above and the growing emphasis on home care, it will become essential to focus on research and development (R&D) to produce innovative, cost-efficient, superior and multipurpose products for debridement. With the growing trend towards simpler, sophisticated, efficient and painless treatment, workshops and conferences will prove beneficial to introduce and promote the existence and functioning of these products.
European Markets for Wound Debridement is part of the Medical Devices Subscription, which also includes research in the following markets: mechanical debridement, chemical debridement, autolytic debridement, biological debridement. All research included in subscriptions provide detailed market opportunities and industry trends that have been evaluated following extensive interviews with market participants. Interviews with the press are available.
Frost & Sullivan, a global growth consulting company, has been partnering with clients to support the development of innovative strategies for more than 40 years. The company's industry expertise integrates growth consulting, growth partnership services, and corporate management training to identify and develop opportunities. Frost & Sullivan serves an extensive clientele that includes Global 1000 companies, emerging companies, and the investment community by providing comprehensive industry coverage that reflects a unique global perspective and combines ongoing analysis of markets, technologies, econometrics, and demographics. For more information, visit www.frost.com.
European Markets for Wound Debridement
BA1A-54
Shwetha Thomas, Corporate Communications - South Asia & Middle East, Frost & Sullivan, + 91 (022) 4001 3429 sthomas@frost.com
Radhika Menon Theodore, Corporate Communications - Europe, Frost & Sullivan, + 91 (044) 4204 4541 rmtheodore@frost.com
Source: Frost & Sullivan (Business Wire India)
Press release presented here is sourced from the Source mentioned above and is provided on as-is basis. Please contact the Company / Source directly for any further information in regard to this release. This website will be unable to assist you in regard to the accuracy or correctness of information in this release.
